19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
04.09.2018
- German biopharma Affimed has agreed a strategic collaboration with Genentech, part of Swiss drug giant Roche, to develop immunotherapies for multiple cancers. Affimed will apply...
26.07.2018
- Swiss pharmaceutical giant Roche has signed up to a multi-year collaboration with PureTech Health, a US clinical stage biopharma focused on the brain-immune-gut axis. The partners...
20.06.2018
- Swiss drugmaker Roche is paying $2.4 billion to acquire the rest of the shares it does not already own in US molecular and genomic analysis company Foundation Medicine (FMI). The...
05.06.2018
- The digital developments in the healthcare industry, combined with an aging population and enormous scientific progress, pose new challenges for pharmaceutical companies. On the...
17.04.2018
- For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...
21.02.2018
- Swiss drugmaker Roche has agreed to acquire all of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, in which it...
04.01.2018
- Roche is planning to buy US group Ignyta for around $1.7 billion in an all-cash deal that will expand the Swiss group’s portfolio of cancer medicines. San Diego, California-based...
